9th - 10th November 2021

2nd Annual MarketsandMarkets Single-Cell Analysis Virtual Conference

Single-cell analysis is crucial for discovering population heterogeneity, identifying minority sub-populations of interest, and discovering unique properties of individual cells. Microfluidic systems operate on a scale comparable to cell width and are capable of manipulating single cells. Single-cell sequencing is a new and powerful technique for studying the evolution and variety of most malignancies, as well as the involvement of circulating tumour cells in cancer progression. These techniques have begun to answer critical problems in cancer biology that have been difficult to answer using bulk tumour measurements. The technology and applications of single-cell analysis have advanced dramatically in the last five years.

Recent breakthroughs in single cell technology have offered new possibilities for identifying intra-tumor cell heterogeneity, identifying unusual cell types, and determining the degree of mutation, all of which can help guide diagnoses and therapy options.

 

Our 2nd Annual MarketsandMarkets Virtual conference on 2nd Annual Single-Cell analysis scheduled to be held on 9th and 10th November goal is to bring together researchers and scientists from top universities and pharmaceutical companies from all over the world to discuss significant innovations and difficulties in single-cell analysis, as well as provide a platform for academic peers to share their experiences and reveal their research articles and reports.

WHAT TO EXPECT
Key Highlights
  • Innovations in Single-cell Analysis
  • Addressing the challenges in isolating Single-cell
  • Microfluidics and Single-cell investigations
  • Technological advancements in the detection of Metastatic cancer
  • Single-cell sequencing progress in cancer genetics
  • Spatial Transcriptomics
  • Single-cell RNA-Sequencing
  • Combined techniques (RNA-seq and TAP-seq) used to help in medical advancements
  • Computational Analysis in Single-cell Biology
  • Whole genome/transcriptome amplification (WGA/WTA) for Single-cell genomic analysis
Who Should Attend?
  • Universities

            Designation- Professors, Researchers, Associate professors, Directors- specializing in Bioinformatics, Genetics, Translational medicine, Cell therapy , Cell biology, Cytogenetics, Translational Genomics, Medicine, Computational Biology , Pathology, Molecular Biology, Microbiology, Pharmacogenomics, Chemistry, Bioengineering

  • Pharma/Therapeutics

           Designation: CEO, COO, Senior Scientist, Research Scientist, Single Cell Specialist, Single Cell Bioinformatician, Application Scientist NGS etc

Why Attend?
  • Learn about single-cell biology and how it can be utilized.
  • Meet industrial and academic leaders and researchers from across the world. 
  • Post-summit accessibility to on-demand online presentations Case studies from prominent technological collaborations
  • Program aims to address recent scientific difficulties.
  • Interactive panel discussions
  • The Technological-Application based Agenda 
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Pamela Pinzani

Pamela Pinzani

Associate Professor Clinical Biochemistry
University of Florence

Pamela Pinzani

Associate Professor Clinical Biochemistry
University of Florence
Yu-Hwa Lo

Yu-Hwa Lo

Director
San Diego Nanotechnology Infrastructure (SDNI)

Yu-Hwa Lo

Director
San Diego Nanotechnology Infrastructure (SDNI)
Anka G. Ehrhardt

Anka G. Ehrhardt

Science Director (Clinical Research)
CHDI Foundation

Anka G. Ehrhardt

Science Director (Clinical Research)
CHDI Foundation
Ryan Kelly

Ryan Kelly

Associate Professor
Brigham Young University

Ryan Kelly

Associate Professor
Brigham Young University
Shanrong Zhao

Shanrong Zhao

Vice President (Data Sciences)
AbSci

Shanrong Zhao

Vice President (Data Sciences)
AbSci
Anoja Perera

Anoja Perera

Director Sequencing and Discovery Genomics
Stowers Institute for Medical Research

Anoja Perera

Director Sequencing and Discovery Genomics
Stowers Institute for Medical Research
Ramya Gamini

Ramya Gamini

Principal Scientist (Computational Biology)
Pfizer

Ramya Gamini

Principal Scientist (Computational Biology)
Pfizer
Catherine Alix-Panabières

Catherine Alix-Panabières

Director of the Laboratory Rare Circulating Human Cells (LCCRH)
l’Université et CHU de Montpellier

Catherine Alix-Panabières

Director of the Laboratory Rare Circulating Human Cells (LCCRH)
l’Université et CHU de Montpellier
SPONSORS
Silver
example-image

Mission Bio

Speaking Partner
example-image

S2 Genomics

PAST EVENT GALLERY